Literature DB >> 8493022

The efficacy of optical and pharmacological penalization.

M X Repka1, J M Ray.   

Abstract

PURPOSE: Optical and pharmacological penalization of sound eyes are infrequently used alternatives to occlusion for treating amblyopia. The authors evaluated the efficacy of penalization as their primary treatment of amblyopia.
METHODS: One hundred sixty-six patients underwent penalization treatment for strabismic or anisometropic amblyopia for a minimum of 3 months. Both atropine and optical penalization methods were used.
RESULTS: Visual acuity improved in 67 (77%) of 87 patients treated with optical penalization. There was a significant improvement of the geometric mean visual acuity of the amblyopic eyes from 20/38 to 20/28 (P < 0.001). Visual acuity of 60 (76%) of 79 patients treated with pharmacological penalization improved. There was a significant improvement of mean visual acuity of the amblyopic eyes from 20/61 to 20/40 (P < 0.001). Neither therapy produced an instance of occlusion amblyopia. Thirteen patients discontinued therapy because of blur or discomfort.
CONCLUSION: This study demonstrates that penalization methods are effective methods for the treatment of amblyopia, with a low risk of occlusion amblyopia. Patient acceptance of these methods was excellent. Penalization should be considered more often for the primary treatment of amblyopia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8493022     DOI: 10.1016/s0161-6420(93)31577-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Amblyopia therapy.

Authors:  B W Fleck
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Atropine penalisation versus occlusion as the primary treatment for amblyopia.

Authors:  A Foley-Nolan; A McCann; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

3.  Screening for visual impairment in children younger than age 5 years: recommendation statement.

Authors: 
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

4.  A randomized trial of adding a plano lens to atropine for amblyopia.

Authors:  David K Wallace; Elizabeth L Lazar; Michael X Repka; Jonathan M Holmes; Raymond T Kraker; Darren L Hoover; Katherine K Weise; Amy L Waters; Melissa L Rice; Robert J Peters
Journal:  J AAPOS       Date:  2015-02       Impact factor: 1.220

Review 5.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

6.  Conventional occlusion versus pharmacologic penalization for amblyopia.

Authors:  Tianjing Li; Riaz Qureshi; Kate Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-08-28

7.  Rebalancing binocular vision in amblyopia.

Authors:  Jian Ding; Dennis M Levi
Journal:  Ophthalmic Physiol Opt       Date:  2014-01-12       Impact factor: 3.117

8.  The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies.

Authors:  J T Flynn; J Schiffman; W Feuer; A Corona
Journal:  Trans Am Ophthalmol Soc       Date:  1998

9.  Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials.

Authors:  Michael X Repka; Raymond T Kraker; Roy W Beck; Eileen Birch; Susan A Cotter; Jonathan M Holmes; Richard W Hertle; Darren L Hoover; Deborah L Klimek; Wendy Marsh-Tootle; Mitchell M Scheiman; Donny W Suh; David R Weakley
Journal:  J AAPOS       Date:  2009-06       Impact factor: 1.220

10.  Light transmission and preference of eye patches for occlusion treatment.

Authors:  Hwan Heo; Jung Won Park; Sang Woo Park
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.